Universal Therapeutics Group Sdn Bhd
Established in 2014 as Hesed Baracah Medical Group Limited and rebranded as Universal Therapeutics Group in 2020, we are a leading provider of In Vitro Diagnostics (IVDs) headquartered in Malaysia. Our state-of-the-art manufacturing facility has been certified with the ISO13485:2016 QMS, ensuring the highest standards of quality and performance for our IVDs. With our commitment to accuracy, reliability, and affordability, we have become a trusted partner for IVDs, serving customers across the globe. Our purpose at Universal Therapeutics is strive to make a positive impact in the healthcare industry and improve the lives of those we serve.
See below for the latest Universal Therapeutics Group Sdn Bhd News, Analysis, Profit Results, Share Price Information and Commentary
Commentary
Why HR in Asia needs stronger culture governance, not louder transformation promises
Malaysian brands know what they want to be — their incentive structures disagree
Asia plays part in $129t global credit market pool
Rethinking the role of video infrastructure in Asian retail
Why APAC digital leaders must overhaul content amidst fractured consumer discovery
Why bigger digesters alone won't solve Asia's renewable energy challenge
Only the agile will win across ASEAN’s evolving markets
Scaling for resilience: What Asia Pacific’s bioenergy markets can learn from each other
Asia is leading payments modernisation and banks can't afford to fall behind
‘Tokenmaxxing’ – The wrong AI race to run in Singapore